PPIDT00107
Drug Information
| Name | Pramlintide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB01278 |
| Type | small molecule |
| Indication | For the treatment of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection | Subcutaneous |
0.6 mg/1mL
|
| Injection | Subcutaneous |
600 ug/1mL
|
| Injection | Subcutaneous |
1000 ug/1mL
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P43220 | GLP1R | Glucagon-like peptide 1 receptor | Homo sapiens | agonist | Link |
| target | P30988 | CALCR | Calcitonin receptor | Homo sapiens | agonist | Link |
| target | O60894 | RAMP1 | Receptor activity-modifying protein 1 | Homo sapiens | agonist | Link |
| target | O60895 | RAMP2 | Receptor activity-modifying protein 2 | Homo sapiens | agonist | Link |
| target | O60896 | RAMP3 | Receptor activity-modifying protein 3 | Homo sapiens | agonist | Link |